These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9184724)

  • 21. Riluzole use during pregnancy in a patient with amyotrophic lateral sclerosis: a case report.
    Kawamichi Y; Makino Y; Matsuda Y; Miyazaki K; Uchiyama S; Ohta H
    J Int Med Res; 2010; 38(2):720-6. PubMed ID: 20515588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of riluzole on symptom progression in amyotrophic lateral sclerosis.
    Sojka P; Andersen PM; Forsgren L
    Lancet; 1997 Jan; 349(9046):176-7. PubMed ID: 9111546
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of riluzole on the relationship between patient and physician.
    Dengler R; Tröger M
    J Neurol; 1997 May; 244 Suppl 2():S30-2. PubMed ID: 9178169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cotreatment of amyotrophic lateral sclerosis patients].
    Iwasaki Y; Ikeda K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1253-5. PubMed ID: 10791091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.
    Dash RP; Babu RJ; Srinivas NR
    Clin Pharmacokinet; 2018 Nov; 57(11):1385-1398. PubMed ID: 29682695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
    Dyer AM; Smith A
    Drug Des Devel Ther; 2017; 11():59-64. PubMed ID: 28053507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Riluzole treatment in advanced ALS.
    Borasio GD
    J Neurol; 2002 May; 249(5):505-6. PubMed ID: 12021937
    [No Abstract]   [Full Text] [Related]  

  • 30. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
    Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of amyotrophic lateral sclerosis with riluzole.
    Neatherlin JS
    J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
    Mignani S; Majoral JP; Desaphy JF; Lentini G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32707914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.
    Bruno R; Vivier N; Montay G; Le Liboux A; Powe LK; Delumeau JC; Rhodes GR
    Clin Pharmacol Ther; 1997 Nov; 62(5):518-26. PubMed ID: 9390108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective agents for clinical trials in ALS: a systematic assessment.
    Traynor BJ; Bruijn L; Conwit R; Beal F; O'Neill G; Fagan SC; Cudkowicz ME
    Neurology; 2006 Jul; 67(1):20-7. PubMed ID: 16832072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System.
    Vu M; Tortorice K; Zacher J; Dong D; Hur K; Zhang R; Good CB; Glassman PA; Cunningham FE
    JAMA Netw Open; 2020 Oct; 3(10):e2014645. PubMed ID: 33017028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.